Skip to content

side effects

Articles tagged with “side effects

8 articles
Side Effects & Dropout Rates: New Data on Ketamine for TRD visual guide

Side Effects & Dropout Rates: New Data on Ketamine for TRD

New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insight for patients considering ketamine therapy for TRD.

Read
news

Why Patients Quit NMDA Therapy, And What Providers Should Do

New clinical review urges faster dose optimization and earlier switching between NMDA therapies for treatment-resistant depression. Here's what it means for patients.

news

NMDA Side Effects: What Dropout Rates Mean for Patients

New clinical guidance on NMDA antagonist side effects and dropout rates offers practical insights for patients considering ketamine or esketamine therapy.

news

Ketamine Side Effects: What New Clinical Data Reveals

New clinical analysis examines side effect profiles and discontinuation rates for ketamine and esketamine. Here's what treatment-resistant depression patients should know.

news

Ketamine Side Effects: What New Data Tells Patients

A new clinical review examines side effect profiles and discontinuation rates for NMDA antagonists like ketamine and esketamine. Here's what patients should know.

news

Ketamine Side Effects: What New Data Means for Patients

New clinical guidance on NMDA antagonist side effects and discontinuation rates gives patients and families sharper questions to ask before starting ketamine therapy.

safety

Managing Ketamine Side Effects: What to Expect and How to Cope

Managing ketamine therapy side effects, practical tips for handling nausea, dissociation, dizziness, and other common effects during and after treatment.

safety

Is Ketamine Therapy Safe? Understanding the Risks and Benefits

An honest, evidence-based look at the safety of ketamine therapy, covering side effects, contraindications, long-term considerations, and how to minimize risk.

Need help or want to reach readers?

Have a correction, provider question, or advertising inquiry? Reach the editorial team.